SCHEMBL5571695

SCHEMBL5571695

COc1cc(OC)c(-c2cc3ccccc3s2)cc1C(=O)C=Cc1cc(OC)c(OC)c(OC)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNFRSF1A P19438 10/20 0.69
ALDH1A1 P00352 2/20 0.55
MAPT P10636 2/20 0.55
LMNA P02545 1/20 0.55
TUBB4A P04350 2/20 0.53
TUBB P07437 2/20 0.53
TUBA3C P0DPH7 2/20 0.53
TUBA1B P68363 2/20 0.53
TUBA4A P68366 2/20 0.53
TUBB4B P68371 2/20 0.53
TUBB3 Q13509 2/20 0.53
TUBB2A Q13885 2/20 0.53
TUBB8 Q3ZCM7 2/20 0.53
TUBA3E Q6PEY2 2/20 0.53
TUBA1A Q71U36 2/20 0.53
TUBA1C Q9BQE3 2/20 0.53
TUBB6 Q9BUF5 2/20 0.53
TUBB2B Q9BVA1 2/20 0.53
TUBB1 Q9H4B7 2/20 0.53
ABCB1 P08183 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5574920 0.92 TNFRSF1A (0.69) TNFRSF1AALDH1A1MAPTLMNAABCG2
SCHEMBL5571806 0.90 TNFRSF1A (0.66) TNFRSF1AMAPTABCG2MEN1KMT2A
SCHEMBL5571725 0.84 TNFRSF1A (0.73) TNFRSF1ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5571727 0.84 TNFRSF1A (0.73) TNFRSF1ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5575927 0.84 TNFRSF1A (0.73) TNFRSF1AALDH1A1MAPTLMNATUBB4A
SCHEMBL5575692 0.84 TNFRSF1A (0.73) TNFRSF1AALDH1A1MAPTLMNATUBB4A
SCHEMBL5574886 0.82 TNFRSF1A (1.00) TNFRSF1AABCB1
SCHEMBL5574888 0.82 TNFRSF1A (1.00) TNFRSF1AABCB1
SCHEMBL5573398 0.81 TNFRSF1A (0.68) TNFRSF1ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5573396 0.81 TNFRSF1A (0.68) TNFRSF1ATUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247714-B2 Protection against oxidative stress and inflammation by a cytoprotective response element ATHEROGENICS, INC. (US) 2007-07-24 US disclosed
US-20040023233-A1 Protection against oxidative stress and inflammation by a cytoprotective response element CRABTREE ACQUISITION CO, LLC 2004-02-05 US disclosed
WO-2003033662-A2 PROTECTION AGAINST OXIDATIVE STRESS AND INFLAMMATION BY A CYTOPROTECTIVE RESPONSE ELEMENT ATHEROGENICS, INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040023233-A1 Protection against oxidative stress and inflammation by a cytoprotective response element ATF4, HSF1, DDIT3 TNFRSF1A 1169/4885ALDH1A1 3531/4885MAPT 4833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.